Forte Biosciences, Inc. (FBRX)
NASDAQ$5.52
Market Cap
$35.29M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
280 of 924
Rank in Industry
161 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
FBRX Insider Trading Activity
FBRX Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $124,998 | 1 | 100 |
Sells | $0 | 0 | 0 |
Related Transactions
| Riley Antony A | CHIEF FINANCIAL OFFICER | 1 | $124,998 | 0 | $0 | $124,998 |
About Forte Biosciences, Inc.
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Insider Activity of Forte Biosciences, Inc.
Over the last 12 months, insiders at Forte Biosciences, Inc. have bought $124,998 and sold $0 worth of Forte Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Forte Biosciences, Inc. have bought $147,732 and sold $4.45M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Riley Antony A (CHIEF FINANCIAL OFFICER) — $124,998.
The last purchase of 22,514 shares for transaction amount of $124,998 was made by Riley Antony A (CHIEF FINANCIAL OFFICER) on 2024‑11‑21.
List of Insider Buy and Sell Transactions, Forte Biosciences, Inc.
| 2024-11-21 | Riley Antony A | CHIEF FINANCIAL OFFICER | 22,514 0.5477% | $5.55 | $124,998 | +1.28% | ||
| 2023-12-18 | Wagner Paul A. | See Remarks | 10,000 0.0286% | $0.75 | $7,525 | -16.54% | ||
| 2023-12-14 | Wagner Paul A. | See Remarks | 10,000 0.0287% | $0.72 | $7,200 | -13.84% | ||
| 2023-12-13 | Wagner Paul A. | See Remarks | 10,520 0.0284% | $0.70 | $7,351 | -14.63% | ||
| 2023-12-12 | Wagner Paul A. | See Remarks | 4,776 0.013% | $0.65 | $3,088 | -8.74% | ||
| 2023-12-11 | Wagner Paul A. | See Remarks | 25,000 0.0719% | $0.65 | $16,188 | -2.03% | ||
| 2023-12-08 | Wagner Paul A. | See Remarks | 15,000 0.0406% | $0.62 | $9,300 | -2.52% | ||
| 2023-12-07 | Wagner Paul A. | See Remarks | 36,203 0.0971% | $0.58 | $21,168 | +2.62% | ||
| 2023-11-22 | Wagner Paul A. | See Remarks | 400 0.0011% | $0.43 | $172 | +35.40% | ||
| 2023-11-20 | Wagner Paul A. | See Remarks | 6,966 0.0175% | $0.44 | $3,048 | +18.95% | ||
| 2022-12-16 | Wagner Paul A. | See Remarks | 44,024 0.2759% | $1.07 | $47,000 | +2.04% | ||
| 2022-12-15 | Wagner Paul A. | See Remarks | 55,976 0.3253% | $1.03 | $57,672 | -1.96% | ||
| 2021-09-07 | Sale | Wagner Paul A. | See Remarks | 1M 7.2851% | $4.35 | $4.35M | -65.57% | |
| 2021-09-07 | Sale | Riley Antony A | Chief Financial Officer | 25,000 0.1778% | $4.24 | $106,105 | -65.57% | |
| 2020-06-29 | Riley Antony A | Chief Financial Officer | 2,000 0.0544% | $14.11 | $28,220 | +145.46% | ||
| 2020-06-26 | Riley Antony A | Chief Financial Officer | 4,700 0.1262% | $14.52 | $68,225 | +135.52% | ||
| 2020-06-25 | Wagner Paul A. | See Remarks | 7,000 0.1998% | $14.48 | $101,356 | +150.76% | ||
| 2020-04-14 | Oliveira Steven Michael | 10 percent owner | 74,301 0.1242% | $1.19 | $88,418 | +54.56% | ||
| 2020-03-02 | Oliveira Steven Michael | 10 percent owner | 65,149 0.0283% | $1.35 | $87,756 | -0.52% | ||
| 2019-05-30 | Hasnain Faheem | director | 43,000 0.0242% | $4.66 | $200,315 | -77.34% |
Total: 28
*Gray background shows transactions not older than one year
Insider Historical Profitability
69.41%
| Riley Antony A | CHIEF FINANCIAL OFFICER | 30776 0.4814% | $169,883.52 | 3 | 1 | +140.49% |
| Oliveira Steven Michael | 10 percent owner | 2873450 44.9446% | $15.86M | 2 | 0 | +27.02% |
| Wagner Paul A. | See Remarks | 1823236 28.5178% | $10.06M | 12 | 1 | +50.28% |
| Hasnain Faheem | director | 245857 3.8455% | $1.36M | 2 | 0 | |
| FOLETTA MARK G | EVP & Chief Financial Officer | 15042 0.2353% | $83,031.84 | 2 | 0 |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$14,315,062 | 61 | -6.21% | $33.06M | |
$22,186,116 | 57 | -43.73% | $37.31M | |
$53,490,060 | 55 | 19.35% | $30.29M | |
$23,895,365 | 34 | -37.28% | $37.97M | |
$17,594,514 | 16 | -20.37% | $33.77M |
FBRX Institutional Investors: Active Positions
| Increased Positions | 15 | +48.39% | 4M | +497.97% |
| Decreased Positions | 12 | -38.71% | 129,955 | -17.64% |
| New Positions | 9 | New | 2M | New |
| Sold Out Positions | 8 | Sold Out | 91,368 | Sold Out |
| Total Postitions | 34 | +9.68% | 4M | +480.33% |
FBRX Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Fred Alger Management, Llc | $6,577.00 | 18.9% | 1.13M | +1M | +1,271.19% | 2024-12-31 |
| Tybourne Capital Management (Hk) Ltd | $3,596.00 | 10.33% | 619,981 | +475,000 | +327.63% | 2024-12-31 |
| Ikarian Capital, Llc | $3,534.00 | 10.15% | 609,225 | +609,225 | New | 2024-12-31 |
| Orbimed Advisors Llc | $3,480.00 | 10% | 600,000 | +600,000 | New | 2024-12-31 |
| Bvf Inc/Il | $3,447.00 | 9.9% | 594,282 | +475,000 | +398.22% | 2024-12-31 |
| Cable Car Capital, Lp | $1,274.00 | 3.66% | 219,604 | +138,325 | +170.19% | 2024-12-31 |
| Woodline Partners Lp | $1,185.00 | 3.41% | 204,275 | +204,275 | New | 2024-12-31 |
| Perceptive Advisors Llc | $555.00 | 1.6% | 95,742 | 0 | 0% | 2024-12-31 |
| Boothbay Fund Management, Llc | $517.00 | 1.49% | 89,191 | +89,191 | New | 2024-12-31 |
| Farallon Capital Management Llc | $203.00 | 0.58% | 35,000 | -37,413 | -51.67% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
No data is available at this moment.
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.